Antibody Society KOREA 2019

PharmAbcine, a clinical stage immune-oncology company, today announced that Dr. Jin-San Yoo, Chairman and Chief Executive Officer of PharmAbcine is invited to give a presentation covering R&D progress of PharmAbcine's Bispecific antibodies at ASK (Antibody Society KOREA) Conference in Sokcho on July 4th, 2019.

Please check the attached file for details.